Kendrick A Goss

US Patent:

20050215764, Sep 29, 2005

Filed:

Feb 18, 2005

Appl. No.:

11/060868

Inventors:

Jack Tuszynski - Edmonton, CA
Kendrick Goss - Brighton MA, US
Howard Greenwald - Rochester NY, US

International Classification:

C07K014/47

US Classification:

530358000

Abstract:

A biological polymer assembly with a biological polymer that contains at least 90 percent of tubulin and a positively charged segment. The positively charged segment has a molecular weight of at least about 5,000 Daltons, a bulk electrical conductivity of at least about 10ohmsmeterSiemens, a concentration of elemental charges per cubic centimeter of from about 10to about 10, and a length of at least about 2 nanometers.

US Patent:

20050249667, Nov 10, 2005

Filed:

Jun 7, 2005

Appl. No.:

11/147125

Inventors:

Jack Tuszynski - Edmonton, CA
Kendrick Goss - Brighton MA, US
Howard Greenwald - Rochester NY, US
Garold Fritz - Williamson NY, US

International Classification:

A61B005/055
H01S001/06

US Classification:

424009300

Abstract:

A process for treating cells within a biological organism in which sonic energy is focused on cells within a biological organism while the frequency and/or the power level of such energy is varied. In addition there is provided a process for synergistically combining sonic energy and other forms of energy, or other therapeutic agents, in the treatment of cells in living organisms. Furthermore there is provided a process for assaying the efficacy of other therapeutic agents with sonic energy.

US Patent:

20060147371, Jul 6, 2006

Filed:

Feb 23, 2005

Appl. No.:

11/063439

Inventors:

Jack Tuszynski - Edmonton, CA
Howard Greenwald - East Rochester NY, US
Stephen Curry - Rochester NY, US
Kendrick Goss - Brighton MA, US

International Classification:

A61K 51/00
A61K 49/10

US Classification:

424001110, 424009320

Abstract:

A water-soluble magnetic anti-mitotic compound with a water-solubility of at least 100 micrograms per milliliter, a molecular weight of at least 150 grams per mole, a mitotic index factor of at least 10 percent, a positive magnetic susceptibility of at least 1,000×10cgs, and a magnetic moment of at least 0.5 bohr magnetrons, wherein said compound is comprised of at least 7 carbon atoms and at least one inorganic atom with a positive magnetic susceptibility of at least 200×10cgs.

US Patent:

20070027129, Feb 1, 2007

Filed:

Feb 23, 2005

Appl. No.:

11/064247

Inventors:

Jack Tuszynski - Edmonton, CA
Howard Greenwald - East Rochester NY, US
Stephen Curry - Rochester NY, US
Kendrick Goss - Brighton MA, US

International Classification:

A61K 31/555
C07F 15/02

US Classification:

514185000, 514449000, 549510000, 549206000

Abstract:

A water-soluble magnetic anti-mitotic compound with a water-solubility of at least 100 micrograms per milliliter, a molecular weight of at least 150 grams per mole, a mitotic index factor of at least 10 percent, a positive magnetic susceptibility of at least 1,000×10cgs, and a magnetic moment of at least 0.5 bohr magnetrons, wherein said compound is comprised of at least 7 carbon atoms and at least one inorganic atom with a positive magnetic susceptibility of at least 200×10cgs.

US Patent:

20070092549, Apr 26, 2007

Filed:

Feb 23, 2005

Appl. No.:

11/063441

Inventors:

Jack Tuszynski - Edmonton, CA
Howard Greenwald - East Rochester NY, US
Stephen Curry - Rochester NY, US
Kendrick Goss - Brighton MA, US

International Classification:

A61F 2/20
A61K 31/337

US Classification:

424423000, 514449000, 427002240

Abstract:

A water-soluble magnetic anti-mitotic compound with a water-solubility of at least 100 micrograms per milliliter, a molecular weight of at least 150 grams per mole, a mitotic index factor of at least 10 percent, a positive magnetic susceptibility of at least 1,000×10cgs, and a magnetic moment of at least 0.5 bohr magnetrons, wherein said compound is comprised of at least 7 carbon atoms and at least one inorganic atom with a positive magnetic susceptibility of at least 200×10cgs.

US Patent:

20070149496, Jun 28, 2007

Filed:

Aug 20, 2004

Appl. No.:

10/923615

Inventors:

Jack Tuszynski - Edmonton, CA
Howard Greenwald - Rochester NY, US
Stephen Curry - Rochester NY, US
Kendrick Goss - Brighton MA, US

International Classification:

A61K 31/555
C07F 15/02

US Classification:

514184000, 549206000

Abstract:

A water-soluble magnetic anti-mitotic compound with a water-solubility of at least 100 micrograms per milliliter, a molecular weight of at least 150 grams per mole, a mitotic index factor of at least 10 percent, a positive magnetic susceptibility of at least 1,000×10cgs, and a magnetic moment of at least 0.5 bohr magnetrons, wherein said compound is comprised of at least 7 carbon atoms and at least one inorganic atom with a positive magnetic susceptibility of at least 200×10cgs.

US Patent:

20080119421, May 22, 2008

Filed:

Oct 28, 2004

Appl. No.:

10/976274

Inventors:

Jack Tuszynski - Edmonton, CA
Howard J. Greenwald - Rochester NY, US
Stephen H. Curry - Rochester NY, US
Kendrick Goss - Brighton MA, US

International Classification:

A61K 31/704
A61K 31/706
A61K 31/282
A61K 31/675
A61K 31/195
A61P 35/00
A61K 31/337
A61K 31/4985
A61K 31/35
A61K 31/7072

US Classification:

514 34, 514 49, 514492, 514 90, 514452, 514 50, 514249, 514564, 514449, 514457

Abstract:

A process for treating a biological organism, comprising the steps in which a cell cycle arresting drug is administered to the organism to produce synchronized cells, the microtubules within the synchronized cells are stabilized by means of a microtubule stabilizing agent, and the synchronized cells with the stabilized microtubules are then contacted with mechanical vibrational energy.

US Patent:

20080287856, Nov 20, 2008

Filed:

Jun 10, 2008

Appl. No.:

12/155824

Inventors:

Stuart G. MacDonald - Pultneyville NY, US
Jack A. Tuszynski - Edmonton, CA
Kendrick Goss - Brighton MA, US
Michael L. Weiner - Webster NY, US
Robert W. Gray - Rochester NY, US
Amara D. Angelica - Webster NY, US

Assignee:

Biomed Solutions LLC - Pittsford NY

International Classification:

A61B 18/18
A61M 5/00

US Classification:

604 20

Abstract:

An apparatus for treating a biological organism comprising a device for emitting and delivering energy to the biological organism, a programmable controller for varying the type and amount of energy emitted, and apparatus for sensing a condition of the biological organism.